The tumor necrosis factor B (TNFB) gene is closely liked with tumor necrosis factor A (TNFA) gene between the HLA-B and C2 genes on chromosome 6p21.3. Several genetic variabilities at the human TNFB loci have been identified, which are the NcoI restriction fragment length p01ymorphism (RFLP) in the first intron, amino acid substitution at codon 26 ofexon 3 and EcoRI RFLP in untranslated exon 4. The NcoI RFLP of TNFB gene gives two allelic fragments of 238/259 bp and 497 bp, corresponding to TNFB*I and TNFB*2 alleles, respectively. To investigate the frequency of NcoI RFLP in the first intron of TNFB in Koreans and to compare to that of other ethnic population, genomic DNAs were extracted from leukocytes of 305 unrelated healthy Koreans and amplified the first intron of TNFB gene by PCR. The phenotype frequencies of NcoI RFLP such as TNFB*I/TNFB*I, TNFB*I/ TNFB*2 and TNFB*2/TNFB*2 were 8.6% (n=26), 45.2% (n= 138) and 46.2% (n=141), respectively. The estimated allele frequencies for TNFB*I and TNFB*2 were 0.3115 and 0.6885, respectively. The observed and expected frequencies were in good agreement with the HardyWeinberg's equilibrium. The heterozygosity revealed 45.2% and the allele frequencies of NcoI RFLP of TNFB in Koreans were observed comparatively similar to those of other ethnic groups.
Introduction
Tumor necrosis factor fl (TNF fl; lymphotoxin) is a cytokine predominantly secreted by macrophage but also by activated lymphocytes (Sung et al., 1988a, b) . It has a high cytotoxicity to wide range of tumor cells and mediate to inflammation and graft rejection. TNF-fl share 30% amino acid homology with tumor necrosis K.-S. PARK et alo factor-a (TNF-a) and show similar cytostatic and cytolytic activities in vitro and in vivo.
A gene encoding TNF-fl gene (TNFB) is located in tandem with the TNF-a gene (TNFA) between the HLA-B and C2 genes Spies et al., 1986) on chromosome 6p21.3 (Nedwin et al., 1985) . The TNFB gene consists of four exons, which are untranslated exon 1, partially untranslated exon 4 and three introns. The cDNA revealed that a predicted length of 205 amino acids derived from 238 residue long precursor and produced a 25 kDa cytokine.
Structural and regulatory polymorphism in the human TNFB gene has been reported previously. The nucleotide sequence differences of a biallelic polymorphism were found in the TNFB gene (Abraham et al., 1991) . One of these differences was found to be located in exon 1, the 5' untranslated region of the gene. A single base transition of A to G appears in the exon 1. Another nucleotide difference was found in the first intron, corresponding to a point mutation at NcoI site (G vs A). The third nucleotide difference resulted in a polymorphism of exon 3, which differed in its amino acid at position 26 of TNF-fl protein (C vs A). And additional restriction fragment length polymorphism (RFLP) has been demonstrated for the TNFB gene with the use of the restriction endonuclease, EeoRI (Partanen and Koskimies, 1988) and AecI (Webb and Chaplin, 1990) , however, it was not allelic in nature.
The NcoI polymorphism in the first intron of TNFB gene allows two alleles, TNFB*I and TNFB*2 (Webb and Chaplin, 1990; Messer et al., 1991; Abraham et al., 1991) . TNFB*I carries the NcoI restriction site, lacking in TNFB*2 due to a point mutation which segregates with the biallelic system in family study (Bettinotti et al., 1993) . Yamagata et al. (1991) have found the polymorphic NcoI restriction site located in the first intron of the TNFB gene by PCR-NeoI-RFLP. Messer et al. (1991) have showed that two TNFB alleles differ by one amino acid at position 26 that conserved as asparagine in the TNFB* 1 and as threonine in the TNFB * 2.
The NcoI RFLP in the first intron of TNFB variation is not only regarded as a genetic marker but also known for its involvement in regulation of TNF-fl and TNF-a expression (Pociot et al., 1993) ; the TNFB*2/TNFB*2 homozygote may be associated with autoimmune-like disease (Partanen and Koskimies, 1988) and allowing better prognosis of lung or gastric cancer Shimura et al., 1994 Shimura et al., , 1995 .
In present paper, we have characterized the variation in the first intron of TNFB gene in Koreans by PCR-N¢oI-RFLP and the frequencies have been compared to those of other ethnic groups.
Materials and Methods
Genomic DNA was extracted from peripheral blood of 305 unrelated Koreans using QIAamp Blood kit (Qiagen, USA). For TNFB NcoI RFLP analyses, the following primers were used: TNFBI, 5' GCA CAG CAG GTG AGG CTC TCC 3" and TNFB2, 5' GGT GGT GCC ACA CAC CCT TGG 3" (Yamagata et al., 1991) . The reaction mixture contained 20 pmol of each primer, 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 0.001% gelatin, 1.5 mM MgClz, 200/.tM of dNTPs and 1 unit of Taq DNA polymerase (Poscochem, Korea). The initial denaturation time was 4 rain. And amplification was performed at 95°C for 1 min/63°C for 15 sec/72°C for 20 sec during 35 cycles by Perkin/Elmer thermocycler 9600. The expected 497 bp band was amplified, directly digested with 1 unit of restriction enzyme NcoI (Boehringer Mannheim, Germany) for 3 hr at 37°C. The fragments obtained after amplification and digestion were analyzed by 5% of polyacrylamide gel electrophoresis and stained with ethidium bromide. The band cleaved with NcoI represented as the TNFB*I type (238/259 bp), and that not cleaved, as the TNFB*2 type (497 bp).
Results and Discussion
NcoI RFLP in the TNFB gene was studied in 305 unrelated Koreans. The amplified 497 bp fragment was contained NcoI polymorphic site in the first intron of TNFB gene. Amplification and NcoI restriction of the first intron resulted in two different patterns of fragments. The TNFB* 1 allele corresponded to 259/238 bp of NcoI fragment with the presence of G sequence, and TNFB*2 allele corresponded to 497 bp fragment, which lacks the NcoI restriction site. Individuals carrying the heterozygo.us TNFB*I/TNFB*2 for NcoI RFLP of TNFB intron 1 showed three fragments, such as 497 bp, 259 bp and 238 bp bands by 5% of polyacrylamide gel electrophoresis (Fig. 1) .
The first intron of TNFB genotype and allele frequencies were shown in Table  1 . The gene frequencies were 0.3115 for TNFB*I allele and 0.6885 for TNFB*2. The heterozygosity at TNFB intron 1 was 45.2%. No deviation from the expectation according to the Hardy-Weinberg equilibrium was found. Table 2 showed the genotype frequencies of NcoI RFLP in the first intron of TNFB gene in other ethnic groups. The frequencies of TNFB*I/TNFB*I were shown below 12.7% in most of populations. The frequency of NcoI RFLP in the first intron of TNFB in Koreans was similar to that of the other ethnic groups. Chung et al. (1994) had previously reported NcoI RELP in the first intron of TNFB in 129 Koreans. However, they have shown that the phenotype frequency of the rare TNFB allele TNFB* 1/TNFB* 1 homozygote was significantly higher than our result (21.7% vs 8.6%, p<0.0l). This difference might be due to less number of subjects in the experiment.
Recently, there have been many reports of which the polymorphism of the TNFB RFLPs might be involved in differential TNF-a or -/3 secretion. Individuals carrying the TNFB*2 of NcoI RFLP in intron 1 had a higher TNF-a secretory capacity than those carrying the TNFB*I (Pociot et al., 1993) . Messer et al. (1991) have characterized the TNFB*I which presents significantly higher Vo [. 42, No. 2, 1997 Laitinen et al,, 1992 TNF-fl mRNA and protein synthesis upon PHA stimulation of peripheral blood mononuclear cell and T lymphocytes than the TNFB*2 allele does. TNF-a secretion by monocytes from individuals depends on different TNFB genotypes.
Because the TNF-oe potentiates the cytostatic/cytotoxic effects, although further studies are necessary, we suggest that TNFB* 2/TNFB* 2 associated with increased amounts of TNF-a secretion may be correlated with a resistance to cancer and lead to a better prognosis.
